Results per Page:
Hidden cancer-associated microRNAs emerge from ribosomal DNA repeats
From the Henikoff Lab, Basic Sciences Division
Rethinking the cost of curing sickle cell disease
From the Cancer Consortium and the UW CHOICE Institute
Viral sparks sustain mpox transmission in Los Angeles
From the Bedford Lab, Vaccine and Infectious Disease Division
Una segunda oportunidad para los linfocitos T-CAR en el osteosarcoma
Del laboratorio de Meshinchi, Departamento de Investigación Clínica y Departamento de Ciencias Traslacionales y Terapéutica
Dying cells signal the thymus to rebuild
From the Dudakov Lab, Translational Science and Therapeutics Division
Reading between the cells: How MRD details predict AML relapse
From the Walter Lab, Translational Science and Therapeutics Division
Carrera contra reloj: Cronogramas más cortos mejoran las predicciones de la gripe
Del Laboratorio Bedford, Departamento de Vacunas y Enfermedades Infecciosas
Extramedullary disease shapes toxicity risk in BCMA CAR T therapy
From the Gauthier Group, Clinical Research Division
Giving CAR T a second life in osteosarcoma
From the Meshinchi Lab, Clinical Research Division and Translational Science and Therapeutics Division
Down to the wire: Shorter timelines make better flu predictions
From the Bedford Lab, Vaccine and Infectious Disease Division
Hidden reactivation, active immunity: Mapping the immune response to HSV-2
From the Lund Lab, Vaccine and Infectious Disease Division
Foot on the gas: How RIT1 and YAP accelerate lung adenocarcinoma
From the Berger Lab, Human Biology Division
A moving target: How spike’s shape determines immune escape in SARS-CoV-2
From the Bloom Lab, Basic Sciences Division
AMOTL2 multitasks to control cell growth and Zika virus infection
From the Overbaugh Lab, Human Biology Division
A cellular epic starring eIF1 and eIF5
From the Lapointe Lab, Basic Sciences Division
Del tratamiento a la transición: Apoyo a la atención primaria en la supervivencia del cáncer
De la Dra. Jean Yi y sus colegas del Consorcio Oncológico de UW y Fred Hutch
Tracking rhabdomyosarcoma’s return: A focus on gene fusions
From the Mian Lab, Precision Radiation Sciences Lead Radiation Oncology Division and the Cancer Consortium
Robarle una base al cáncer: la edición de precisión para una inmunoterapia más segura
Del Laboratorio Kiem, División de Ciencias Traslacionales y Terapéuticas
From treatment to transition: Supporting primary care in cancer survivorship
From Dr. Jean Yi and colleagues at the UW & Fred Hutch Cancer Consortium
Stealing a base from cancer: precision editing for safer immunotherapy
From the Kiem Lab, Translational Science and Therapeutics Division